Effects of α1-adrenoceptor antagonists on pupil diameter and intraurethral pressure in rabbits

Japanese Pharmacology and Therapeutics

Volumn 34, Issue 6, 2006, Pages 653-661

  Watanabe, Mai ^a   Ohtake, Akiyoshi ^a   Yuyama, Hironori ^a   Yanai Inamura, Hiroko ^a   Ukai, Masashi ^a   Someya, Akiyoshi ^a   Okutsu, Hiroko ^a   Noguchi, Yukiko ^a   Suzuki, Masanori ^a   Sasamata, Masao ^a   Michel, Martin C ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Alfuzosin; Doxazosin; Intraurethral pressure; Miosis; Naftopidil; Prazosin; Pupil diameter; Silodosin; Tamsulosin; Terazosin

Indexed keywords

ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; NAFTOPIDIL; PHENYLEPHRINE; PRAZOSIN; SILODOSIN; TAMSULOSIN; TERAZOSIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; INHIBITION KINETICS; MIOSIS; MYDRIASIS; NONHUMAN; RABBIT; URETHRA PRESSURE;

EID: 40949132643     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. α1-adrenoceptor antagonist. Yakugaku Zasshi-Journal of the Pharmaceutical Society of Japan 1995; 115: 773-89.
2. Murayama K, Katsumi T, Tajika E, Kawaguchi K, Ueki O. Clinical evaluation of tamsulosin hydrochloride on bladder outlet obstruction associated with benign prostatic hyperplasia: effect on urethral pressure profile and cystometrogram. Hinyokika Kiyo-Acta Urologica Japonica 1997; 43: 799-803.
3. Narayan P, Evans CP, Moon T. Long-term safety and efficacy of tamsulosin for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. J Urol 2003; 170: 498-502.
4. Chang DF, Campbell JR. Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg 2005; 31: 664-73.
5. Pärssinen O. The use of tamsulosin and iris hypotony during cataract surgery. Acta Ophthalmol Scand 2005; 83: 624-6.
6. α1B-adrenergic receptors in the rat iris. Cell Tissue Res 1998; 293: 435-44.
7. α1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA. Br J Pharmacol 1999; 127: 1367-74.
8. Suzuki F, Tanignchi T, Nakamura S, Akagi Y, Kubota C, Satoh M, et al. Distribution of alpha-1 adrenoceptor subtypes in RNA and protein in rabbit eyes. Br J Pharmacol 2002; 135: 600-8.
9. Vidovic M, Hill CE. Alpha adrenoceptor gene expression in the rat iris during development and maturity. Dev Brain Res 1995; 89: 309-13.
10. a1-adrenoceptor subtypes in the eye. Exp Eye Res 2000; 70: 51-60.
11. α1-adrenoceptors in iris dilator muscle of humans, and albino and pigmented rabbits. Naunyn-Schmiedebergs Arch Pharmacol 1996; 354: 765-72.
12. α1A-adrenoceptors mediate sympathetically evoked pupillary dilation in rats. J Pharmacol Exp Ther 2002; 300: 521-5.
13. α-adrenoceptor antagonists on sympathetic mydriasis in rabbits. J Ocul Pharmacol Ther 2003; 19: 255-63.
14. Clarke RJ, Zhang H, Gamlin PDR. Characteristics of the pupillary light reflex in the alert rhesus monkey. J Neurophysiol 2003; 89: 3179-89.
15. a1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits. Naunyn-Schmiedebergs Arch Pharmacol 2006; 372: 345-53.
16. α1-Adrenoceptor subtype selectivity and organ specificity of Silodosin (KMD-3213. Yakugaku Zasshi-Journal of the Pharmaceutical Society of Japan 2006; 126: 209-16.
17. Yokota T. Urodynamic characteristics during animal hypnosis in the rabbit. Nippon Hinyokika Gakkai Zasshi 1990; 81: 1659-66.
18. α-adrenoceptors mediating pupillary dilation in rats. Eur J Pharmacol 2003; 471: 135-40.
19. α1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy. Eur J Pharmacol 1995; 288: 201-7.
20. α1-adrenoceptor subtypes and in human prostate. J Auton Pharmacol 1996; 16: 21-8.
21. α2- and β-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 2006; 147: S88-S119.
22. α1-adrenoceptors. Jpn J Pharmacol 1999; 79: 447-54.
23. α2-adrenoceptor antagonists produce opposing mydriatic effects by a central action. J Auton Pharmacol 1988; 8: 229-39.
24. α1-Adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study. Eur J Pharmacol 1994; 261: 59-64.
25. 14C-tamsulosin hydrochloride in rats and dogs. Oyo Yakuri/Pharmacometrics 1990; 40: 101-9.
26. Yamaguchi T. The Effects of Naftpidil on Blood Pressure, Heart Rate and Plasma Norepinephrin Level in Freely Moving Rabbits. Jpn Pharmacol Ther 1996; 24: 1239-43.
27. Takayanagi I, Konno F, Kameda H, Kubo H, Furukawa A, Toyoda T. A difference in mode of antagonism between optical isomers of a potent selective alpha1-adrenoceptor blocker (YM- 12617 and norepinephrine in isolated rabbit iris dilator and aorta. Jpn J Pharmacol 1986; 42: 579-82.
28. α1A-adrenoceptor agonist, in pigmented rats. Arzneimittelforschung 2001; 51: 402-7.
29. Salazar-Bookaman MM, Wainer I, Patil PN. Relevance of drug-melanin interactions to ocular pharmacology and toxicology. J Ocul Pharmacol 1994; 10: 217-39.